Abbott Laboratories (0Q15) Ownership - Who Owns Abbott Laboratories?
Abbott Laboratories (0Q15) Ownership Overview
- 0.48% Insiders
- 21.88% Mutual Funds
- 3.63% Other Institutional Investors
- 25.66% ETFs
- 48.36% Public Companies and Individual Investors
The ownership structure of Abbott Laboratories (GB:0Q15) stock is a mix of institutional, retail, and individual investors. Approximately 51.16% of the company’s stock is owned by Institutional Investors, 0.48% is owned by Insiders, and 48.36% is owned by Public Companies and Individual Investors.
The ownership structure of Abbott Laboratories (GB:0Q15) stock is a mix of institutional, retail, and individual investors. Approximately 51.16% of the company’s stock is owned by Institutional Investors, 0.48% is owned by Insiders, and 48.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 02, 2026 | John A. Jr. Mccoy | $8,696 | |
| Aug 26, 2026 | Robert Ford | $46,204,798 | |
| Aug 12, 2026 | Louis H. Morrone | $642,506 | |
| Jun 17, 2026 | John Stratton | $173,640 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Manning & Napier Advisors Llc | $21,424 | |
| Dec 31, 2025 | Howard Hughes Medical Institute | $46,983 | |
| Dec 31, 2025 | Riverstone Advisors, Llc | $228,153 | |
| Dec 31, 2025 | Invst, Llc | $322,621 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 156,041,226 | Institution | 9.02% | 16,573,138,613 |
| Vanguard Index Funds | 119,048,349 | Institution | 6.88% | 12,644,125,147 |
| Ishares | 89,121,338 | Institution | 5.15% | 9,465,577,309 |
| Spdr | 73,243,916 | Institution | 4.23% | 7,779,236,318 |
| Schwab | 47,398,560 | Institution | 2.74% | 5,034,201,058 |
| Fidelity Concord Street Trust | 30,765,010 | Institution | 1.78% | 3,267,551,712 |
| Washington Mutual Investors Fund | 17,527,923 | Institution | 1.01% | 1,861,640,702 |
| Ubs | 15,043,988 | Institution | 0.87% | 1,597,821,965 |
| Vanguard Specialized Funds | 13,574,522 | Institution | 0.78% | 1,441,749,982 |
| Invesco | 12,773,385 | Institution | 0.74% | 1,356,661,221 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 119,048,349 | Institution | 6.88% | 12,644,125,147 |
| Fidelity Concord Street Trust | 30,765,010 | Institution | 1.78% | 3,267,551,712 |
| Washington Mutual Investors Fund | 17,527,923 | Institution | 1.01% | 1,861,640,702 |
| Vanguard Specialized Funds | 13,574,522 | Institution | 0.78% | 1,441,749,982 |
| Investment Co Of America | 10,330,842 | Institution | 0.60% | 1,097,238,729 |
| Vanguard Institutional Index Funds | 10,289,873 | Institution | 0.59% | 1,092,887,411 |
| Vanguard World Fund | 9,121,780 | Institution | 0.53% | 968,824,254 |
| American Mutual Fund | 8,092,368 | Institution | 0.47% | 859,490,405 |
| Mfs Series Trust I | 7,920,154 | Institution | 0.46% | 841,199,556 |
| Tiaa-cref Funds | 7,465,826 | Institution | 0.43% | 792,945,379 |
FAQ
Who Owns Abbott Laboratories (GB:0Q15)?
According to the latest TipRanks data, approximately 51.16% of the company's stock is held by institutional investors, 0.48% is held by insiders, and 48.36% is held by public companies and individual investors.
What percentage of Abbott Laboratories (GB:0Q15) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.16% of Abbott Laboratories (GB:0Q15) stock is held by institutional investors: 21.88% by mutual funds, 25.66% by ETFs and 3.63% by other institutional investors.
What percentage of Abbott Laboratories (GB:0Q15) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.36% of Abbott Laboratories (GB:0Q15) stock is held by public companies and individual investors.
Who owns the most shares of Abbott Laboratories (GB:0Q15)?
Vanguard owns the most shares of Abbott Laboratories (GB:0Q15).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.